VNDA

Vanda Pharmaceuticals Inc.

4.95 USD
-0.28 (-5.35%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vanda Pharmaceuticals Inc. stock is up 2.7% since 30 days ago. The next earnings date is Jul 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.37% of the previous 18 May’s closed higher than April. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Apr 14:07 17 May, 2024 5.00 CALL 200 89
03 Apr 17:37 19 Apr, 2024 5.00 CALL 486 2490
15 May 13:38 20 Dec, 2024 3.00 CALL 110 350
15 May 13:48 20 Dec, 2024 3.00 CALL 100 350

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders. Its products under development include Fanapt (iloperidone) and Tradipitant (VLY-686) The company markets its products in the United States, Europe, and Israel.